 | • レポートコード：MRC2012B0224 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、伝染病治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。伝染病治療の種類別市場規模（HIV、インフルエンザ、結核、マラリア、肝炎、HPV）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Boehringer Ingelheim、Janssen Pharmaceutical、Gilead、Merck、GSK、BioCryst Pharmaceuticals、Roche、 ・地域別グローバル市場分析 2015年-2020年 ・伝染病治療の北米市場（アメリカ、カナダ、メキシコ） ・伝染病治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・伝染病治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・伝染病治療の南米市場（ブラジル、アルゼンチン） ・伝染病治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：HIV、インフルエンザ、結核、マラリア、肝炎、HPV ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Communicable Diseases Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Communicable Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Communicable Diseases Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Communicable Diseases Treatment market has been segmented into:
HIV
Influenza
TB
Malaria
Hepatitis
HPV
By Application, Communicable Diseases Treatment has been segmented into:
Hospital
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Communicable Diseases Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Communicable Diseases Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Communicable Diseases Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Communicable Diseases Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Communicable Diseases Treatment Market Share Analysis
Communicable Diseases Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Communicable Diseases Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Communicable Diseases Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Communicable Diseases Treatment are:
Novartis
Boehringer Ingelheim
Janssen Pharmaceutical
Gilead
Merck
GSK
BioCryst Pharmaceuticals
Roche
Table of Contents
1 Communicable Diseases Treatment Market Overview
1.1 Product Overview and Scope of Communicable Diseases Treatment
1.2 Classification of Communicable Diseases Treatment by Type
1.2.1 Global Communicable Diseases Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Communicable Diseases Treatment Revenue Market Share by Type in 2019
1.2.3 HIV
1.2.4 Influenza
1.2.5 TB
1.2.6 Malaria
1.2.7 Hepatitis
1.2.8 HPV
1.3 Global Communicable Diseases Treatment Market by Application
1.3.1 Overview: Global Communicable Diseases Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Communicable Diseases Treatment Market by Regions
1.4.1 Global Communicable Diseases Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Communicable Diseases Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Communicable Diseases Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Communicable Diseases Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Communicable Diseases Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Communicable Diseases Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Communicable Diseases Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Communicable Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Boehringer Ingelheim SWOT Analysis
2.2.4 Boehringer Ingelheim Product and Services
2.2.5 Boehringer Ingelheim Communicable Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen Pharmaceutical
2.3.1 Janssen Pharmaceutical Details
2.3.2 Janssen Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen Pharmaceutical SWOT Analysis
2.3.4 Janssen Pharmaceutical Product and Services
2.3.5 Janssen Pharmaceutical Communicable Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Gilead
2.4.1 Gilead Details
2.4.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Gilead SWOT Analysis
2.4.4 Gilead Product and Services
2.4.5 Gilead Communicable Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Communicable Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Communicable Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 BioCryst Pharmaceuticals
2.7.1 BioCryst Pharmaceuticals Details
2.7.2 BioCryst Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BioCryst Pharmaceuticals SWOT Analysis
2.7.4 BioCryst Pharmaceuticals Product and Services
2.7.5 BioCryst Pharmaceuticals Communicable Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche SWOT Analysis
2.8.4 Roche Product and Services
2.8.5 Roche Communicable Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Communicable Diseases Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Communicable Diseases Treatment Players Market Share
3.2.2 Top 10 Communicable Diseases Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Communicable Diseases Treatment Revenue and Market Share by Regions
4.2 North America Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
5 North America Communicable Diseases Treatment Revenue by Countries
5.1 North America Communicable Diseases Treatment Revenue by Countries (2015-2020)
5.2 USA Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
6 Europe Communicable Diseases Treatment Revenue by Countries
6.1 Europe Communicable Diseases Treatment Revenue by Countries (2015-2020)
6.2 Germany Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
6.4 France Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Communicable Diseases Treatment Revenue by Countries
7.1 Asia-Pacific Communicable Diseases Treatment Revenue by Countries (2015-2020)
7.2 China Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
7.5 India Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
8 South America Communicable Diseases Treatment Revenue by Countries
8.1 South America Communicable Diseases Treatment Revenue by Countries (2015-2020)
8.2 Brazil Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Communicable Diseases Treatment by Countries
9.1 Middle East & Africa Communicable Diseases Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Communicable Diseases Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Communicable Diseases Treatment Market Forecast by Type (2019-2024)
10.3 HIV Revenue Growth Rate (2015-2025)
10.4 Influenza Revenue Growth Rate (2015-2025)
10.5 TB Revenue Growth Rate (2015-2025)
10.6 Malaria Revenue Growth Rate (2015-2025)
10.7 Hepatitis Revenue Growth Rate (2015-2025)
10.8 HPV Revenue Growth Rate (2015-2025)
11 Global Communicable Diseases Treatment Market Segment by Application
11.1 Global Communicable Diseases Treatment Revenue Market Share by Application (2015-2020)
11.2 Communicable Diseases Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Communicable Diseases Treatment Market Size Forecast (2021-2025)
12.1 Global Communicable Diseases Treatment Market Size Forecast (2021-2025)
12.2 Global Communicable Diseases Treatment Market Forecast by Regions (2021-2025)
12.3 North America Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
12.6 South America Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Communicable Diseases Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Communicable Diseases Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Communicable Diseases Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Communicable Diseases Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Communicable Diseases Treatment Major Business
Table 7. Novartis Communicable Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Communicable Diseases Treatment Product and Solutions
Table 10. Novartis Communicable Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 12. Boehringer Ingelheim Communicable Diseases Treatment Major Business
Table 13. Boehringer Ingelheim Communicable Diseases Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Boehringer Ingelheim SWOT Analysis
Table 15. Boehringer Ingelheim Communicable Diseases Treatment Product and Solutions
Table 16. Boehringer Ingelheim Communicable Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Janssen Pharmaceutical Corporate Information, Location and Competitors
Table 18. Janssen Pharmaceutical Communicable Diseases Treatment Major Business
Table 19. Janssen Pharmaceutical Communicable Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Janssen Pharmaceutical SWOT Analysis
Table 21. Janssen Pharmaceutical Communicable Diseases Treatment Product and Solutions
Table 22. Janssen Pharmaceutical Communicable Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Gilead Corporate Information, Location and Competitors
Table 24. Gilead Communicable Diseases Treatment Major Business
Table 25. Gilead Communicable Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Gilead SWOT Analysis
Table 27. Gilead Communicable Diseases Treatment Product and Solutions
Table 28. Gilead Communicable Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Merck Corporate Information, Location and Competitors
Table 30. Merck Communicable Diseases Treatment Major Business
Table 31. Merck Communicable Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Merck SWOT Analysis
Table 33. Merck Communicable Diseases Treatment Product and Solutions
Table 34. Merck Communicable Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GSK Corporate Information, Location and Competitors
Table 36. GSK Communicable Diseases Treatment Major Business
Table 37. GSK Communicable Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 38. GSK SWOT Analysis
Table 39. GSK Communicable Diseases Treatment Product and Solutions
Table 40. GSK Communicable Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. BioCryst Pharmaceuticals Corporate Information, Location and Competitors
Table 42. BioCryst Pharmaceuticals Communicable Diseases Treatment Major Business
Table 43. BioCryst Pharmaceuticals Communicable Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 44. BioCryst Pharmaceuticals SWOT Analysis
Table 45. BioCryst Pharmaceuticals Communicable Diseases Treatment Product and Solutions
Table 46. BioCryst Pharmaceuticals Communicable Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Roche Corporate Information, Location and Competitors
Table 48. Roche Communicable Diseases Treatment Major Business
Table 49. Roche Communicable Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Roche SWOT Analysis
Table 51. Roche Communicable Diseases Treatment Product and Solutions
Table 52. Roche Communicable Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Communicable Diseases Treatment Revenue (Million USD) by Players (2015-2020)
Table 54. Global Communicable Diseases Treatment Revenue Share by Players (2015-2020)
Table 55. Global Communicable Diseases Treatment Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Communicable Diseases Treatment Revenue Market Share by Regions (2015-2020)
Table 57. North America Communicable Diseases Treatment Revenue by Countries (2015-2020)
Table 58. North America Communicable Diseases Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Europe Communicable Diseases Treatment Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Communicable Diseases Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Communicable Diseases Treatment Revenue by Countries (2015-2020)
Table 62. South America Communicable Diseases Treatment Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Communicable Diseases Treatment Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Communicable Diseases Treatment Revenue Market Share by Countries (2015-2020)
Table 65. Global Communicable Diseases Treatment Revenue (Million USD) by Type (2015-2020)
Table 66. Global Communicable Diseases Treatment Revenue Share by Type (2015-2020)
Table 67. Global Communicable Diseases Treatment Revenue Forecast by Type (2021-2025)
Table 68. Global Communicable Diseases Treatment Revenue by Application (2015-2020)
Table 69. Global Communicable Diseases Treatment Revenue Share by Application (2015-2020)
Table 70. Global Communicable Diseases Treatment Revenue Forecast by Application (2021-2025)
Table 71. Global Communicable Diseases Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Communicable Diseases Treatment Picture
Figure 2. Global Communicable Diseases Treatment Revenue Market Share by Type in 2019
Figure 3. HIV Picture
Figure 4. Influenza Picture
Figure 5. TB Picture
Figure 6. Malaria Picture
Figure 7. Hepatitis Picture
Figure 8. HPV Picture
Figure 9. Communicable Diseases Treatment Revenue Market Share by Application in 2019
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Other Picture
Figure 13. Global Communicable Diseases Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Communicable Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Communicable Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Communicable Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Communicable Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Communicable Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Communicable Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Communicable Diseases Treatment Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Communicable Diseases Treatment Revenue Market Share in 2019
Figure 22. Global Top 10 Players Communicable Diseases Treatment Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Communicable Diseases Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Communicable Diseases Treatment Revenue Market Share by Regions (2015-2020)
Figure 26. Global Communicable Diseases Treatment Revenue Market Share by Regions in 2018
Figure 27. North America Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Europe Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 30. South America Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 32. North America Communicable Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. North America Communicable Diseases Treatment Revenue Market Share by Countries in 2019
Figure 34. USA Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Canada Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Europe Communicable Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Communicable Diseases Treatment Revenue Market Share by Countries in 2019
Figure 39. Germany Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 40. UK Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 41. France Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Russia Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Italy Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Communicable Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Communicable Diseases Treatment Revenue Market Share by Countries in 2019
Figure 46. China Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Japan Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Korea Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 49. India Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 51. South America Communicable Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. South America Communicable Diseases Treatment Revenue Market Share by Countries in 2019
Figure 53. Brazil Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Communicable Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Communicable Diseases Treatment Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 58. UAE Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Communicable Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Global Communicable Diseases Treatment Revenue Share by Type (2015-2020)
Figure 62. Global Communicable Diseases Treatment Revenue Share by Type in 2019
Figure 63. Global Communicable Diseases Treatment Market Share Forecast by Type (2021-2025)
Figure 64. Global HIV Revenue Growth Rate (2015-2020)
Figure 65. Global Influenza Revenue Growth Rate (2015-2020)
Figure 66. Global TB Revenue Growth Rate (2015-2020)
Figure 67. Global Malaria Revenue Growth Rate (2015-2020)
Figure 68. Global Hepatitis Revenue Growth Rate (2015-2020)
Figure 69. Global HPV Revenue Growth Rate (2015-2020)
Figure 70. Global Communicable Diseases Treatment Revenue Share by Application (2015-2020)
Figure 71. Global Communicable Diseases Treatment Revenue Share by Application in 2019
Figure 72. Global Communicable Diseases Treatment Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Revenue Growth Rate (2015-2020)
Figure 74. Global Clinic Revenue Growth Rate (2015-2020)
Figure 75. Global Other Revenue Growth Rate (2015-2020)
Figure 76. Global Communicable Diseases Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Communicable Diseases Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Communicable Diseases Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 80. Europe Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 82. South America Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Communicable Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
伝染病治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Communicable Diseases Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Communicable Dise…- 希少性肺疾患治療の世界市場（～2026年） Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are e…
- 運動ニューロン疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Motor Neuron Diseases Treatment Market The global Motor Neuron Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Motor Neuron Diseases Treatment Scope and Market Si…
- 豚病治療の世界市場（～2026年） Swine diseases treatments help in improving health, increase production of livestock and prevent transmission of diseases among animals in a cost effective manner. The global swine diseases treatment market is driven by factors such as rapid changing pattern of diseases among the animals. Market Ana…
- 筋骨格系疾患治療の世界市場（～2026年） Musculoskeletal disorders (MSDs) are injuries or pain in the human musculoskeletal system, including the joints, ligaments, muscles, nerves, tendons, and structures that support limbs, neck and back. MSDs can arise from a sudden exertion (e.g., lifting a heavy object)[2], or they can arise from maki…